Discover what's new.

Access the latest news, business developments, company updates, industry trends, events and more.

| By Kelley Gipson

Led by Rosen, Artizan takes aim at inflammation

When James Rosen became president and CEO of Artizan Biosciences, it was a clear signal that Artizan was onto something big. Artizan’s initial product uses...

| By Kelley Gipson

UConn research funding surges to record levels

UConn has hit an impressive new high in external research funding, with its faculty attracting more than $375 million in new awards in the past...

| By Kelley Gipson

Boehringer Ingelheim acquires Abexxa Biologics

Boehringer Ingelheim reports the acquisition of Abexxa Biologics, a Texas biotech. “The acquisition of Abexxa bolsters our commitment to tumor-antigen discovery and new ways of...

| By Kelley Gipson

US News names top CT schools

Several Connecticut colleges and universities made U.S. News and World Report’s annual list of best colleges. UConn again ranks among top 25 national public universities...

| By Kelley Gipson

Sema4 names Stolovitzky Chief Science Officer

Sema4 has appointed Gustavo Stolovitzky, PhD, to the newly established senior leadership position of Chief Science Officer. Dr. Stolovitzky is a world-renowned expert in computational...

| By Kelley Gipson

Astrocyte receives funding for AST-004 project

Astrocyte Pharmaceuticals reports it has received a $3.0M award from the Medical Technology Enterprise Consortium. The award will support the upcoming Phase 1 human safety...

| By Kelley Gipson

NanoViricides licenses COVID drugs from TheraCour

Shelton’s NanoViricides has licensed, from West Haven’s TheraCour Pharma, a set of drugs that show promise against COVID-19. The licensed drugs include antiviral treatments for...

| By Kelley Gipson

Soderstrom’s retirement ends 25-year run at Yale

Jon Soderstrom is retiring, ending a 25-year run as Yale University’s head technology transfer expert. He led Yale’s efforts to boost its profile as a leader of global...